SELECTIVE ESTROGEN RECEPTOR DEGRADERS

يتعلّق الاختراع الحالي بعوامل تحلّل مستقبلات إستروجين انتقائية جديدة selective estrogen receptor degraders (SERDs) وفقًا للصيغة: وأملاح مقبولة صيدليًا pharmaceutically acceptable salts، تركيبات صيدلية pharmaceutical compositions، استخدامات، وطرق الاستخدام. Novel selective estrogen receptor degraders...

Full description

Saved in:
Bibliographic Details
Main Authors COHEN, Jeffrey Daniel, SALL, Daniel Jon
Format Patent
LanguageArabic
English
Published 08.02.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract يتعلّق الاختراع الحالي بعوامل تحلّل مستقبلات إستروجين انتقائية جديدة selective estrogen receptor degraders (SERDs) وفقًا للصيغة: وأملاح مقبولة صيدليًا pharmaceutically acceptable salts، تركيبات صيدلية pharmaceutical compositions، استخدامات، وطرق الاستخدام. Novel selective estrogen receptor degraders (SERDs) according to the formula: pharmaceutically acceptable salts, pharmaceutical compositions, uses, and methods of use thereof are provided.
AbstractList يتعلّق الاختراع الحالي بعوامل تحلّل مستقبلات إستروجين انتقائية جديدة selective estrogen receptor degraders (SERDs) وفقًا للصيغة: وأملاح مقبولة صيدليًا pharmaceutically acceptable salts، تركيبات صيدلية pharmaceutical compositions، استخدامات، وطرق الاستخدام. Novel selective estrogen receptor degraders (SERDs) according to the formula: pharmaceutically acceptable salts, pharmaceutical compositions, uses, and methods of use thereof are provided.
Author SALL, Daniel Jon
COHEN, Jeffrey Daniel
Author_xml – fullname: COHEN, Jeffrey Daniel
– fullname: SALL, Daniel Jon
BookMark eNrjYmDJy89L5WRQDXb1cXUO8QxzVXANDgnyd3f1UwhydXYNCPEPUnBxdQ9ydHENCuZhYE1LzClO5YXS3AxKbq4hzh66qQX58anFBYnJqXmpJfHBjqZGhiZGhgYGZk6GxkQpAgDbzCWA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate عوامل تحلل مستقبلات الإستروجين الانتقائية
ExternalDocumentID SA521421006B1
GroupedDBID EVB
ID FETCH-epo_espacenet_SA521421006B13
IEDL.DBID EVB
IngestDate Fri Jul 19 13:12:09 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Arabic
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_SA521421006B13
Notes Application Number: SA20215421006
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230208&DB=EPODOC&CC=SA&NR=521421006B1
ParticipantIDs epo_espacenet_SA521421006B1
PublicationCentury 2000
PublicationDate 20230208
PublicationDateYYYYMMDD 2023-02-08
PublicationDate_xml – month: 02
  year: 2023
  text: 20230208
  day: 08
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies Eli Lilly And Company
RelatedCompanies_xml – name: Eli Lilly And Company
Score 3.426861
Snippet يتعلّق الاختراع الحالي بعوامل تحلّل مستقبلات إستروجين انتقائية جديدة selective estrogen receptor degraders (SERDs) وفقًا للصيغة: وأملاح مقبولة صيدليًا...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Title SELECTIVE ESTROGEN RECEPTOR DEGRADERS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230208&DB=EPODOC&locale=&CC=SA&NR=521421006B1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTBPMkhLTbPQTTRPMdU1SUsz0gW2MlJ0zVITjcwTk8zNTFJA-519_cw8Qk28IkwjmBiyYXthwOeEloMPRwTmqGRgfi8Bl9cFiEEsF_DaymL9pEygUL69W4itixq0dwxsTxsZWKi5ONm6Bvi7-DurOTvbBjuq-QXZmoKOFjMEJjEnYFeJFdSOBh207xrmBNqWUoBcp7gJMrAFAI3LKxFiYEosEmbgdIZdvSbMwOELnfEGMqGZr1iEQTXY1cfVOcQzzFXBNTgkyN_d1U8hyNXZNSDEP0jBxdU9yBG0X0CUQcnNNcTZQxdoXzzcd_HBjkhuMxZjYAF2-1MlGBRSgI2FNGBnyizRwtAk1cAy0TzZxMQSiJPAh-6ZSTJI4zFICq-sNAMXKLDAq48tZBhYSopKU2WBlWtJkhw4UAD8E3jC
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTkWdH0W0b8Wu9msPRdo0Xaf9oq1jb6VdWxBBx1bx3_caNt3THgIhgUty5HL3S-4uAPeiVoh1VetCrpWKINe1JKCVUQpqlUtaXmiqXLbxzn6gum_yy0yZdeBjEwvD8oT-sOSIKFFzlPeGndeL_0ssm_lWrh6Ld2z6enZSw-bX6BjtaUnUedsyaBTaIeEJMRKTD2JDaVOLDXGLWQiV9jTEhAwrTa02LGWxrVOcI9iPkNxncwydfNmHHtl8vdaHA3_94o3VtfCtTuAhoR4l6WRKOZqkcTimARdTQqM0jDmbjmOzjRc4hTuHpsQVcLzsb3VZYm7N7ekMugj7q3PgSjQWagRTaq4P5Uoc5dpclkdYCpZ0T72AwQ5Clzt7b6Hnpr6XeZPgdQCHLeOYJ7J-Bd1m-V1do6JtihvGoF_GVXus
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=SELECTIVE+ESTROGEN+RECEPTOR+DEGRADERS&rft.inventor=COHEN%2C+Jeffrey+Daniel&rft.inventor=SALL%2C+Daniel+Jon&rft.date=2023-02-08&rft.externalDBID=B1&rft.externalDocID=SA521421006B1